Signalling Pathways 2013
Sitges, Spain - 01 Mar - 02 Mar 2013
Targeting the HER/EGFR family: Focus on breast, lung and colorectal cancers
ESMO aims to implement a series of symposia on signalling pathways for academic clinical researchers and industry researchers. The first of such symposia will focus on the HER family of receptors across lung, breast and colorectal cancers. Starting with the membrane receptors is logical from the biological perspective, but there is also a strong current clinical relevance for medical oncologists. It will be forward looking meeting to bring a new concept of educational workshops in collaborative partnership with industry.